Purine compounds and xanthine oxidase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 473/00 (2006.01) A61K 31/505 (2006.01) C07D 473/18 (2006.01) C07D 473/32 (2006.01) C07D 473/34 (2006.01) C07D 487/14 (2006.01)

Patent

CA 2213420

Purine or triazolopurine compounds represented by general formula (I) or (II), wherein R1 and R4 represent each hydrogen, halogeno, hydroxy, mercapto or amino; R2 represents alkyl or aryl; and R3 and R5 represent each hydrogen, alkyl or aryl; and medicinal compositions comprising these compounds as the active ingredient in particular, xanthin oxidase inhibitors, remedies for hyperuricemia, or remedies or preventives for gout.

Composés de purine ou de triazolopurine représentés par la formule générale (I) ou (II), où R?1¿ et R?4¿ représentent chacun hydrogène, halogèno, hydroxy, mercapto ou amino; R?2¿ représente alkyle ou aryle; et R?3¿ et R?5¿ représentent chacun hydrogène, alkyle ou aryle; ainsi que les compositions médicinales comprenant ces composés comme substance active, et notamment des inhibiteurs de xanthine oxydase, des médicaments pour l'hyperuricémie ou des médicaments curatifs ou préventifs de la goutte.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Purine compounds and xanthine oxidase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Purine compounds and xanthine oxidase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine compounds and xanthine oxidase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1457087

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.